In Australia right now, being up to date with COVID-19 vaccines means you have completed all the doses recommended for your age and individual health needs.1-3 It takes up to 2 weeks after your second dose for your body to build protection (immunity) against the virus.4
The following vaccines are currently provisionally approved for use in Australia:5
- COMIRNATY – Pfizer
- VAXZEVRIA – AstraZeneca
- SPIKEVAX (elasomeran) – Moderna
- SPIKEVAX Bivalent Original/Omicron (elasomeran/imelasomeran) – Moderna (note that this vaccine is not included in Australia’s vaccine rollout)
- NUVAXOVID – Novavax
- COVID-19 Vaccine Janssen – Janssen-Cilag (note that this vaccine is not included in Australia’s vaccine rollout).
Provisional approval means that the vaccine has met the high standards of safety, effectiveness and quality required for use in Australia. This allows for temporary registration and inclusion on the Australian Register of Therapeutic Goods for up to 2 years, with an option to extend provisional registration beyond this initial period.6
Find out more about vaccines and COVID-19.
The Australian Government Department of Health also has information on approved COVID-19 vaccines.
You can download the Approved Product Information or the Consumer Medicine Information for COMINARTY, VAXZEVRIA, SPIKEVAX, SPIKEVAX Bivalent Original/Omicron, NUVAXOVID and COVID-19 Vaccine Janssen from the Therapeutic Goods Administration website.
As of 1 November 2021, the following vaccines (in addition to all provisionally approved vaccines listed above) are recognised for the purpose of travel to Australia:7
- CoronaVac (Sinovac)
- Covishield (AstraZeneca – Serum Institute of India)
- BBIBP-CorV for people aged 18–60 years of age (Sinopharm)
- Covaxin (Bharat Biotech).
A booster dose is an extra dose of a vaccine, given after the primary course. To be up to date with COVID-19 vaccination, booster doses are recommended for people aged 16 years and over.8
Find out more about advice on COVID-19 booster doses.